Ingestible Capsule Bilayer Actuator for On-Command Drug Delivery
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current ingestible devices for gastrointestinal tract diagnosis and treatment lack the ability for precise, on-command deployment of payloads and actuation of mechanical members, such as drug-loaded microneedles or anchors, due to passive dissolution mechanisms and inadequate protection from gastrointestinal fluids and content.
Innovation Solution
A capsule design featuring a bilayer structure with a water-soluble layer and a pH-responsive layer, incorporating a cantilever actuator system with a resistive microheater and magnetic reed switch for controlled deployment of microneedle arrays and actuation, protected by a freestanding hybrid packaging technology.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If passive pH-responsive coatings are used for region-specific targeting, then drug release location is improved, but on-command deployment capability is lost
Solution Approach 1:
The coating system is divided into multiple functional layers: a pH-responsive polymer coating layer for passive targeting and a separate triggerable actuator system for on-command deployment. This segmentation allows each layer to perform its specific function independently, resolving the contradiction between passive targeting precision and active deployment capability.
Solution Approach 2:
A triggerable actuator serves as an intermediary mechanism between the pH-responsive coating and the drug payload. The actuator remains dormant within the coating structure but can be activated by external stimuli (such as magnetic fields or pH changes) to deploy the drug-loaded microneedles at the intended site, combining both passive targeting and on-command deployment capabilities.
2Adaptability or versatility
If movable arms and mechanical members are incorporated for localized delivery, then therapeutic function is improved, but device complexity increases
Solution Approach 1:
The device employs flexible polymer coatings and thin-film structures to encapsulate and protect the mechanical components (movable arms, microneedle arrays). These flexible shells provide protection and structural integrity while allowing the mechanical members to be actuated and deployed, reducing overall device complexity while maintaining localized delivery capability.
Solution Approach 2:
The mechanical members such as microneedle arrays and movable arms are nested within the capsule structure and coating layers. The actuator system is integrated within the capsule body, with the drug-loaded microneedles stored within a protective cavity that opens upon actuation. This nesting approach minimizes the external footprint and reduces perceived complexity while enabling sophisticated localized delivery functions.
3Reliability
If components are protected from GI fluids until deployment site, then reliability is improved, but protection mechanism complexity increases
Solution Approach 1:
The device utilizes composite material structures combining pH-responsive polymers with water-soluble materials and protective coatings. The pH-responsive polymer layer provides environmental responsiveness and protection, while the water-soluble inner layer dissolves at the target site to release the payload. This composite approach enhances reliability through material-level protection mechanisms rather than complex mechanical protection systems.
Solution Approach 2:
The protection mechanism exploits parameter changes in the GI tract environment, specifically pH transitions from acidic (stomach) to neutral/alkaline (intestine). The pH-responsive coating changes its properties based on pH, remaining intact in the acidic stomach environment and dissolving or becoming permeable in the neutral intestinal environment. This parameter-driven protection eliminates the need for complex mechanical protection mechanisms while ensuring reliable component protection until the appropriate deployment site.
4Speed
If fluid is released directly into GI lumen for drug delivery, then delivery speed is improved, but localization precision deteriorates due to turbulent action
Solution Approach 1:
The device replaces the mechanical process of direct fluid injection into the GI lumen with a controlled release mechanism. Drug-loaded microneedles are embedded in a protective coating that dissolves at the target site, allowing drugs to be delivered through tissue penetration rather than direct luminal injection. This substitution maintains rapid delivery speed while achieving precise localization by targeting specific tissue regions rather than relying on turbulent fluid distribution.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables precise and targeted drug delivery and sensing within the gastrointestinal tract by allowing on-command actuation and protection of the actuator system, improving drug localization and reducing systemic exposure and side effects.
Implementation Method 1
a first water-soluble layer at least partially surrounding the capsule (which covers one or more features of the capsule)
Implementation Method 2
a second pH-responsive layer surrounding the capsule and first water-soluble layer
Implementation Method 3
incorporating a cantilever actuator system with a resistive microheater
Implementation Method 4
magnetic reed switch for controlled deployment
Data Source
AI summary
Ingestible capsule devices and methods of making these devices are presented. The device and method provide a capsule with embedded actuator for triggerable delivery of drug loaded structures, a freestanding region responsive bilayer (FRRB) comprising a rigid polyethylene glycol (PEG) layer under a flexible pH-responsive layer of methacrylic acid copolymers which protects capsule content until arrival in their target environment of the intestines. The actuator may be fabricated with a flexible cantilever to store mechanical energy and deploy when released using a heater and meltable polymer. The FRRB may be fabricated to form a multitude of shapes that provide functional packaging mechanisms for an underlying ingestible capsule with one or more features, such as openings or seams.